Equity Profile

DBVT

DBV Technologies S.A.

Health CareBiotechnology$945.8M

Jul27Fri

Pre-Earnings Brief

UpcomingQ4-2024Pre-Market9:00 AM EDT

Company Snapshot

DBV Technologies S.A. is a biotechnology company focused on developing treatments for food allergies and other immune-related conditions....

Key Metrics to Watch

EPS

Earnings per share (EPS) is a key indicator of the company's profitability and financial health.

N/A

Revenue

Revenue figures will provide insight into the company's sales performance and market demand for its products.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

DBVT Q4-2024 Earnings Preview

Context

Company Snapshot

DBV Technologies S.A. is a biotechnology company focused on developing treatments for food allergies and other immune-related conditions. Operating in the health care sector, its innovative approaches aim to improve the quality of life for patients with serious allergies, making it a significant player in the biotechnology industry.

Earnings Scorecard·Last 2Q

EPS Beat Streak

EPS Beat Rate

50%

Avg EPS Surprise

+1.23%

Avg Stock Reaction

-1.28%

Last Quarter Recap

In Q3-2024, DBV Technologies reported an EPS of -$0.32, which was better than the expected -$0.38, resulting in a positive surprise of 15.79%. However, revenue details were not disclosed, leading to a modest stock increase of 1.25% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Investors are cautiously optimistic about DBV Technologies' upcoming earnings report, especially after a slight EPS beat last quarter. However, the lack of revenue guidance leaves uncertainty regarding overall performance.

Bull Case

If DBV Technologies can show improved sales and further reduce losses, it may indicate a strong recovery and growth potential, leading to increased investor confidence.

Bear Case

On the other hand, if the company fails to meet expectations or provides weak guidance, it could signal ongoing challenges in its product development and market acceptance.

Expectations

Two Questions That Matter

The print will turn on these two things.

What is the expected revenue for the quarter?

Revenue figures will be crucial in assessing the company's market performance and growth trajectory, especially given the lack of guidance.

How does management plan to address ongoing losses?

Understanding management's strategy for reducing losses will be key to evaluating the company's future profitability and sustainability.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating the potential for revenue growth based on recent product developments that have not yet been fully recognized.

Supporting Evidence

The recent EPS beat suggests that the company is making strides in managing costs.

Previous quarters have shown volatility, indicating that the market may not fully account for potential recovery.

Key Risk

If revenue significantly exceeds expectations, it could shift the narrative around the company's growth potential.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is currently weighing the potential for growth against the backdrop of ongoing financial challenges.

Bull Confirmed If

A revenue figure that exceeds previous estimates could confirm a positive outlook for the company.

Bear Confirmed If

A significant increase in losses or lack of revenue growth would confirm a negative outlook.

Pre-Earnings Positioning

Options Market

Implied Move

±5%

The options market is pricing in a potential move of 5% in either direction, reflecting uncertainty ahead of the earnings report.

Detail

30d HV

39.9%

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If DBV Technologies beats expectations, history suggests a potential stock increase of around 1.25%, confirming a positive outlook.

In-Line / Cautious

If results are in line with expectations but lack strong guidance, the stock may see muted reactions as investors remain cautious.

Miss

A miss on earnings could lead to a decline of approximately 3.81%, reflecting investor disappointment.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on product development timelines and market readiness.
2Management's commentary on strategies to reduce losses.
3Insights into customer feedback and market demand for their products.
4Guidance on expected revenue for the upcoming quarters.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

CoStar Group, Inc.

Company Snapshot

DBV Technologies S.A. is a biotechnology company focused on developing treatments for food allergies and other immune-related conditions....

Key Metrics to Watch

EPS

Earnings per share (EPS) is a key indicator of the company's profitability and financial health.

N/A

Revenue

Revenue figures will provide insight into the company's sales performance and market demand for its products.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

DBVT Q4-2024 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 2Q

EPS Beat Streak

EPS Beat Rate

50%

Avg EPS Surprise

+1.23%

Avg Stock Reaction

-1.28%

Last Quarter Recap

Management Promises & Guidance

Expectations

Wall Street Expectations

Bull Case

If DBV Technologies can show improved sales and further reduce losses, it may indicate a strong recovery and growth potential, leading to increased investor confidence.

Bear Case

On the other hand, if the company fails to meet expectations or provides weak guidance, it could signal ongoing challenges in its product development and market acceptance.

Expectations

Two Questions That Matter

The print will turn on these two things.

What is the expected revenue for the quarter?

Revenue figures will be crucial in assessing the company's market performance and growth trajectory, especially given the lack of guidance.

How does management plan to address ongoing losses?

Understanding management's strategy for reducing losses will be key to evaluating the company's future profitability and sustainability.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating the potential for revenue growth based on recent product developments that have not yet been fully recognized.

Supporting Evidence

The recent EPS beat suggests that the company is making strides in managing costs.

Previous quarters have shown volatility, indicating that the market may not fully account for potential recovery.

Key Risk

If revenue significantly exceeds expectations, it could shift the narrative around the company's growth potential.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is currently weighing the potential for growth against the backdrop of ongoing financial challenges.

Bull Confirmed If

A revenue figure that exceeds previous estimates could confirm a positive outlook for the company.

Bear Confirmed If

A significant increase in losses or lack of revenue growth would confirm a negative outlook.

Pre-Earnings Positioning

Options Market

Implied Move

±5%

The options market is pricing in a potential move of 5% in either direction, reflecting uncertainty ahead of the earnings report.

Detail

30d HV

39.9%

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If DBV Technologies beats expectations, history suggests a potential stock increase of around 1.25%, confirming a positive outlook.

In-Line / Cautious

If results are in line with expectations but lack strong guidance, the stock may see muted reactions as investors remain cautious.

Miss

A miss on earnings could lead to a decline of approximately 3.81%, reflecting investor disappointment.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on product development timelines and market readiness.
2Management's commentary on strategies to reduce losses.
3Insights into customer feedback and market demand for their products.
4Guidance on expected revenue for the upcoming quarters.